FDA
Also: Livongo names Zane Burke as the next CEO; Atrium Health taps Dr. Rasu Shrestha as VP and chief strategy officer.
Comprised of a Samsung touch screen device and an app-based platfrom, the InterStim smart programmer helps patients and physicians more easily monitor incontinence implants.
Also: Literature review finds telehealth treatments to be on par with in-person care; Survey finds consumers' interest in wearables for health tracking grows.
The eight devices will receive increased guidance and interaction for their clearance efforts, and some will receive Breakthrough Device designation.
According to manufacturer Electrocore, it is the first treatment of any kind to receive the indication.
To encourage healthcare technology innovation and update the 510(k) pathway, the regulatory agency said that it will soon release measures aimed to sunset predicate devices that are over a decade old.
The agency's proposal would classify the majority of software released by pharmas as "promotional labeling" that would not require premarket review.
As AI cements its role in healthcare, more and more intelligent software offerings are pursuing 510(k) and De Novo approvals.
While the company's successful G6 launch was its focus, Dexcom had a busy third quarter for other news as well.
Also: L’Oréal unveils UV sensor clip, companion app; Urinary incontinence wearable receives De Novo clearance.